MedTrace Logo

Cue Reactivity in Virtual Reality: The Role of Context

NCT00862927 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2012-06-20

No results posted yet for this study

Summary

The objectives of this proposal are to examine the role of context in a virtual reality (VR) environment and to explore the extent to which cues (i.e., contextual cues or explicit smoking cues) influence craving and physiological arousal within VR.

The current study seeks to determine whether smokers, placed in the context of a VR convenience store devoid of explicit smoking cues, will experience less craving and physiological arousal, compared to exposure to the same VR environment containing explicit smoking cues. This important line of inquiry will help clarify the influence of environmental contexts that may contribute to the overall reactivity effects (e.g., craving, arousal) smokers experience when confronted with cues associated with smoking.

Conditions

  • Smoking

Interventions

OTHER

Breath Sample

Breathe into machine measuring carbon monoxide.

OTHER

Saliva Sample

Chew cotton ball for 30 seconds for cotinine measurement.

BEHAVIORAL

Questionnaire

6 surveys, taking approximately 30 minutes total.

BEHAVIORAL

View Virtual Reality Scenes

Use virtual reality helmet and hand-held controller to answer questions about 4 viewing scenes while wearing physiological measurement skin sensors, approximately 6 minutes.

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Brian L. Carter, PhD · UT MD Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00862927 on ClinicalTrials.gov